Literature DB >> 2359906

Infections caused by Moraxella, Moraxella urethralis, Moraxella-like groups M-5 and M-6, and Kingella kingae in the United States, 1953-1980.

D R Graham1, J D Band, C Thornsberry, D G Hollis, R E Weaver.   

Abstract

From 1953 to 1980 the Centers for Disease Control received 933 isolates of bacteria belonging to species of the genus Moraxella, Moraxella-like Moraxella urethralis, now renamed Oligella urethralis, unnamed groups M-5 and M-6, and Kingella kingae. Ordinarily sterile sites were the source of 233 isolates. Moraxella nonliquefaciens, the most common isolate (356 strains), was recovered from upper respiratory or ocular sites in 208 (58%) of the cases. Moraxella osloensis was next most common (199 strains) but was the most frequent blood isolate (44 cases). K. kingae appeared especially invasive, with 58 of 78 isolates from blood, bone, or joint. Of the K. kingae strains, 75% were recovered from children under 6 years, compared with 23% of the other strains from that age group (P less than .01). Of the 74 isolates of group M-5, 53 were from wounds caused by dog bites; no other organism in this series was recovered from such wounds. Sixteen of the 28 M. urethralis isolates were from urine. Cases occurred as single infections, with no evidence of clusters. Of patients with infection of ordinarily sterile sites, 9.3% died; only bacteremia, meningitis, and empyema caused fatalities. Most referring laboratories (98%) had not identified the organisms to species, and only 30% had identified them to correct genus. Susceptibility testing by broth dilution revealed low MICs of penicillin (mean, 0.3; 64% less than 1 micrograms/mL). Moraxella, M. urethralis, M-5, M-6, and Kingella are important but frequently misidentified pathogens for humans; penicillin appears to be the treatment of choice.

Entities:  

Mesh:

Year:  1990        PMID: 2359906     DOI: 10.1093/clinids/12.3.423

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  27 in total

1.  Posttrabeculectomy endophthalmitis caused by Moraxella nonliquefaciens.

Authors:  Helene Laukeland; Kåre Bergh; Lars Bevanger
Journal:  J Clin Microbiol       Date:  2002-07       Impact factor: 5.948

2.  Isolation of Kingella kingae from a corneal ulcer.

Authors:  T Mollee; P Kelly; M Tilse
Journal:  J Clin Microbiol       Date:  1992-09       Impact factor: 5.948

3.  The Brief Case: Extragenitourinary Location of Oligella urethralis.

Authors:  Clémence Beauruelle; Hervé Le Bars; Simon Bocher; Didier Tandé; Geneviève Héry-Arnaud
Journal:  J Clin Microbiol       Date:  2019-07-26       Impact factor: 5.948

Review 4.  Kingella kingae: carriage, transmission, and disease.

Authors:  Pablo Yagupsky
Journal:  Clin Microbiol Rev       Date:  2015-01       Impact factor: 26.132

5.  Epidemiological features of invasive Kingella kingae infections and respiratory carriage of the organism.

Authors:  Pablo Yagupsky; Nechama Peled; Orna Katz
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

6.  Peritonitis due to moraxella non liquefaciens.

Authors:  J M G Fandos; M B Mañez
Journal:  Perit Dial Int       Date:  2014 Sep-Oct       Impact factor: 1.756

7.  High prevalence of Kingella kingae in joint fluid from children with septic arthritis revealed by the BACTEC blood culture system.

Authors:  P Yagupsky; R Dagan; C W Howard; M Einhorn; I Kassis; A Simu
Journal:  J Clin Microbiol       Date:  1992-05       Impact factor: 5.948

8.  Panaritium ossale et articulare caused by Moraxella nonliquefaciens.

Authors:  K Piontek; C Herrmann-Czylwik
Journal:  Infection       Date:  1993 Sep-Oct       Impact factor: 3.553

9.  Neisseria weaveri sp. nov., formerly CDC group M-5, a gram-negative bacterium associated with dog bite wounds.

Authors:  B M Andersen; A G Steigerwalt; S P O'Connor; D G Hollis; R S Weyant; R E Weaver; D J Brenner
Journal:  J Clin Microbiol       Date:  1993-09       Impact factor: 5.948

10.  Three cases of Moraxella osloensis meningitis: a difficult experience in species identification and determination of clinical significance.

Authors:  Kyoung Ho Roh; Chang Ki Kim; Eunmi Koh; Myung Sook Kim; Dongeun Yong; Soo Chul Park; Kyungwon Lee; Yunsop Chong
Journal:  J Korean Med Sci       Date:  2010-02-17       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.